Literature DB >> 24412363

The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.

Auinash Kalsotra1, Ravi K Singh1, Priyatansh Gurha2, Amanda J Ward3, Chad J Creighton4, Thomas A Cooper5.   

Abstract

Cardiac dysfunction is the second leading cause of death in myotonic dystrophy type 1 (DM1), primarily because of arrhythmias and cardiac conduction defects. A screen of more than 500 microRNAs (miRNAs) in a DM1 mouse model identified 54 miRNAs that were differentially expressed in heart. More than 80% exhibited downregulation toward the embryonic expression pattern and showed a DM1-specific response. A total of 20 of 22 miRNAs tested were also significantly downregulated in human DM1 heart tissue. We demonstrate that many of these miRNAs are direct MEF2 transcriptional targets, including miRNAs for which depletion is associated with arrhythmias or fibrosis. MEF2 protein is significantly reduced in both DM1 and mouse model heart samples, and exogenous MEF2C restores normal levels of MEF2 target miRNAs and mRNAs in a DM1 cardiac cell culture model. We conclude that loss of MEF2 in DM1 heart causes pathogenic features through aberrant expression of both miRNA and mRNA targets.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24412363      PMCID: PMC3927417          DOI: 10.1016/j.celrep.2013.12.025

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.

Authors:  Melinda L Moseley; Tao Zu; Yoshio Ikeda; Wangcai Gao; Anne K Mosemiller; Randy S Daughters; Gang Chen; Marcy R Weatherspoon; H Brent Clark; Timothy J Ebner; John W Day; Laura P W Ranum
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

Review 3.  Cardiac disease in myotonic dystrophy.

Authors:  M F Phillips; P S Harper
Journal:  Cardiovasc Res       Date:  1997-01       Impact factor: 10.787

4.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 5.  Molecular mechanisms of muscle atrophy in myotonic dystrophies.

Authors:  Lubov Timchenko
Journal:  Int J Biochem Cell Biol       Date:  2013-06-21       Impact factor: 5.085

6.  Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.

Authors:  Arnaud Lazarus; Jean Varin; Dominique Babuty; Frédéric Anselme; Joel Coste; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

7.  Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.

Authors:  Xiaoyan Lin; Jill W Miller; Ami Mankodi; Rahul N Kanadia; Yuan Yuan; Richard T Moxley; Maurice S Swanson; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2006-05-22       Impact factor: 6.150

8.  RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.

Authors:  N A Timchenko; Z J Cai; A L Welm; S Reddy; T Ashizawa; L T Timchenko
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

9.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

Review 10.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors.

Authors:  J D Molkentin; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  48 in total

1.  Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.

Authors:  Alexander Manta; Derek W Stouth; Donald Xhuti; Leon Chi; Irena A Rebalka; Jayne M Kalmar; Thomas J Hawke; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

Review 2.  Earlier and broader roles of Mesp1 in cardiovascular development.

Authors:  Yu Liu
Journal:  Cell Mol Life Sci       Date:  2017-01-03       Impact factor: 9.261

3.  Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.

Authors:  Chiara Fritegotto; Chiara Ferrati; Valentina Pegoraro; Corrado Angelini
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

4.  Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.

Authors:  JuYeon Lee; Yugang Bai; Ullas V Chembazhi; Shaohong Peng; Kevin Yum; Long M Luu; Lauren D Hagler; Julio F Serrano; H Y Edwin Chan; Auinash Kalsotra; Steven C Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

5.  Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

Authors:  Chaitali Misra; Sushant Bangru; Feikai Lin; Kin Lam; Sara N Koenig; Ellen R Lubbers; Jamila Hedhli; Nathaniel P Murphy; Darren J Parker; Lawrence W Dobrucki; Thomas A Cooper; Emad Tajkhorshid; Peter J Mohler; Auinash Kalsotra
Journal:  Dev Cell       Date:  2020-02-27       Impact factor: 12.270

6.  Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.

Authors:  Meiling Zhang; Bo Zhu; Judith Davie
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

Review 7.  Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions.

Authors:  Ginny R Morriss; Thomas A Cooper
Journal:  Hum Genet       Date:  2017-05-08       Impact factor: 4.132

Review 8.  Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead.

Authors:  Hui Tao; Jing-Jing Yang; Wei Hu; Kai-Hu Shi; Zi-Yu Deng; Jun Li
Journal:  Pflugers Arch       Date:  2016-01-20       Impact factor: 3.657

9.  BNANC Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells.

Authors:  Kassie S Manning; Ashish N Rao; Miguel Castro; Thomas A Cooper
Journal:  ACS Chem Biol       Date:  2017-09-05       Impact factor: 5.100

10.  Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells.

Authors:  Rui Liang; Wei Dong; Xiaopeng Shen; Xiaoping Peng; Angie G Aceves; Yu Liu
Journal:  J Vis Exp       Date:  2016-07-29       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.